Expansion of murine periosteal progenitor cells with fibroblast growth factor 2 reveals an intrinsic endochondral ossification program mediated by bone morphogenetic protein 2

Stem Cells

Volumn 32, Issue 9, 2014, Pages 2407-2418

  Van Gastel, Nick ^a   Stegen, Steve ^a   Stockmans, Ingrid ^a   Moermans, Karen ^a   Schrooten, Jan ^a   Graf, Daniel ^b   Luyten, Frank P ^a,c   Carmeliet, Geert ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

Author keywords

Bone morphogenetic protein; Endochondral ossification; Fibroblast growth factor; Periosteum; Tissue engineering

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 2;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CELL; BONE DEFECT; BONE MARROW CELL; BONE MATURATION; BONE REGENERATION; BONE REMODELING; BONE TISSUE; CELL FUNCTION; CONTROLLED STUDY; ENCHONDRAL OSSIFICATION; FEASIBILITY STUDY; FRACTURE HEALING; IN VIVO STUDY; MOUSE; NONHUMAN; PERIOSTEAL PROGENITOR CELL; PROTEIN SECRETION; REGULATORY MECHANISM; STEM CELL; STEM CELL CULTURE; STEM CELL EXPANSION; STEM CELL RESEARCH; STROMA CELL; TISSUE ENGINEERING; TISSUE PRESERVATION; TISSUE REPAIR; ANIMAL; C57BL MOUSE; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PERIOSTEUM; PROCEDURES;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; CELL CULTURE TECHNIQUES; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; MICE; MICE, INBRED C57BL; PERIOSTEUM; STEM CELLS; TISSUE ENGINEERING;

EID: 84906234415     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1783     Document Type: Article

References (52)

1. Colnot C,. Skeletal cell fate decisions within periosteum and bone marrow during bone regeneration. J Bone Miner Res 2009; 24: 274-282.
2. Eyre-Brook AL,. The periosteum: Its function reassessed. Clin Orthop Relat Res 1984; 189: 300-307.
3. Zhang X, Xie C, Lin AS, et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: Implications for functional tissue engineering. J Bone Miner Res 2005; 20: 2124-2137.
4. De Bari C, Dell'Accio F, Vanlauwe J, et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 2006; 54: 1209-1221.
5. Nakahara H, Goldberg VM, Caplan AI,. Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 1991; 9: 465-476.
6. van Gastel N, Torrekens S, Roberts SJ, et al. Engineering vascularized bone: Osteogenic and proangiogenic potential of murine periosteal cells. Stem Cells 2012; 30: 2460-2471.
7. Siddappa R, Licht R, van Blitterswijk C, et al. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res 2007; 25: 1029-1041.
8. Wagers AJ,. The stem cell niche in regenerative medicine. Cell Stem Cell 2012; 10: 362-369.
9. Thies RS, Bauduy M, Ashton BA, et al. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992; 130: 1318-1324.
10. Montero A, Okada Y, Tomita M, et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest 2000; 105: 1085-1093.
11. Xiao L, Liu P, Li X, et al. Exported 18-kDa isoform of fibroblast growth factor-2 is a critical determinant of bone mass in mice. J Biol Chem 2009; 284: 3170-3182.
12. Bianchi G, Banfi A, Mastrogiacomo M, et al. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 2003; 287: 98-105.
13. Coutu DL, Galipeau J,. Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging 2011; 3: 920-933.
14. Eiselleova L, Matulka K, Kriz V, et al. A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 2009; 27: 1847-1857.
15. Kawaguchi H, Nakamura K, Tabata Y, et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 2001; 86: 875-880.
16. Kawaguchi H, Oka H, Jingushi S, et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J Bone Miner Res 2010; 25: 2735-2743.
17. Schmid GJ, Kobayashi C, Sandell LJ, et al. Fibroblast growth factor expression during skeletal fracture healing in mice. Dev Dyn 2009; 238: 766-774.
18. Graf D, Economides AN,. Dissection of bone morphogenetic protein signaling using genome-engineering tools. In:, Vukicevic S, Sampath KT, eds. Bone Morphogenetic Proteins: From Local to Systemic Therapeutics. Basel: Birkhäuser Verlag AG, 2008: 115-139.
19. Maes C, Stockmans I, Moermans K, et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 2004; 113: 188-199.
20. Masuyama R, Stockmans I, Torrekens S, et al. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 2006; 116: 3150-3159.
21. Verhaeghe J, Van Herck E, van Bree R, et al. Osteocalcin during the reproductive cycle in normal and diabetic rats. J Endocrinol 1989; 120: 143-151.
22. Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
23. Yoon DS, Kim YH, Jung HS, et al. Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Prolif 2011; 44: 428-440.
24. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 2004; 11: 1312-1320.
25. Minear S, Leucht P, Miller S, et al. rBMP represses Wnt signaling and influences skeletal progenitor cell fate specification during bone repair. J Bone Miner Res 2010; 25: 1196-1207.
26. Morikawa S, Mabuchi Y, Kubota Y, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009; 206: 2483-2496.
27. Lenas P, Moos M, Luyten FP,. Developmental engineering: A new paradigm for the design and manufacturing of cell-based products. Part I: From three-dimensional cell growth to biomimetics of in vivo development. Tissue Eng Part B Rev 2009; 15: 381-394.
28. Jukes JM, Both SK, Leusink A, et al. Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci USA 2008; 105: 6840-6845.
29. Scotti C, Tonnarelli B, Papadimitropoulos A, et al. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci USA 2010; 107: 7251-7256.
30. Tsuji K, Bandyopadhyay A, Harfe BD, et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006; 38: 1424-1429.
31. Stevens MM, Marini RP, Martin I, et al. FGF-2 enhances TGF-beta1-induced periosteal chondrogenesis. J Orthop Res 2004; 22: 1114-1119.
32. Itkin T, Ludin A, Gradus B, et al. FGF-2 expands murine hematopoietic stem and progenitor cells via proliferation of stromal cells, c-Kit activation, and CXCL12 down-regulation. Blood 2012; 120: 1843-1855.
33. Martin I, Muraglia A, Campanile G, et al. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997; 138: 4456-4462.
34. Coutu DL, Francois M, Galipeau J,. Inhibition of cellular senescence by developmentally regulated FGF receptors in mesenchymal stem cells. Blood 2011; 117: 6801-6812.
35. Chappuis V, Gamer L, Cox K, et al. Periosteal BMP2 activity drives bone graft healing. Bone 2012; 51: 800-809.
36. Wang Q, Huang C, Xue M, et al. Expression of endogenous BMP-2 in periosteal progenitor cells is essential for bone healing. Bone 2011; 48: 524-532.
37. Hirao M, Tamai N, Tsumaki N, et al. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006; 281: 31079-31092.
38. Yamachika E, Tsujigiwa H, Matsubara M, et al. Basic fibroblast growth factor supports expansion of mouse compact bone-derived mesenchymal stem cells (MSCs) and regeneration of bone from MSC in vivo. J Mol Histol 2012; 43: 223-233.
39. Tortelli F, Tasso R, Loiacono F, et al. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 2010; 31: 242-249.
40. Yu YY, Lieu S, Lu C, et al. Bone morphogenetic protein 2 stimulates endochondral ossification by regulating periosteal cell fate during bone repair. Bone 2010; 47: 65-73.
41. Bianco P, Riminucci M, Gronthos S, et al. Bone marrow stromal stem cells: Nature, biology, and potential applications. Stem Cells 2001; 19: 180-192.
42. Itoh S, Aubin JE,. A novel purification method for multipotential skeletal stem cells. J Cell Biochem 2009; 108: 368-377.
43. Sun Y, Li W, Lu Z, et al. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J 2011; 25: 1474-1485.
44. Tian XB, Sun L, Yang SH, et al. Ectopic osteogenesis of mouse bone marrow stromal cells transfected with BMP 2/VEGF(165) genes in vivo. Orthop Surg 2009; 1: 322-325.
45. Krebsbach PH, Kuznetsov SA, Satomura K, et al. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997; 63: 1059-1069.
46. Kuznetsov SA, Grosheva AG, Friedenstein AJ,. Osteogenic properties of adhesive cells from mouse bone marrow Dexter cultures. Biull Eksp Biol Med 1989; 108: 1186-1188.
47. Gomez-Barrena E, Rosset P, Muller I, et al. Bone regeneration: Stem cell therapies and clinical studies in orthopaedics and traumatology. J Cell Mol Med 2011; 15: 1266-1286.
48. Bergman RJ, Gazit D, Kahn AJ, et al. Age-related changes in osteogenic stem cells in mice. J Bone Miner Res 1996; 11: 568-577.
49. Quarto R, Thomas D, Liang CT,. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int 1995; 56: 123-129.
50. Mankani MH, Kuznetsov SA, Fowler B, et al. In vivo bone formation by human bone marrow stromal cells: Effect of carrier particle size and shape. Biotechnol Bioeng 2001; 72: 96-107.
51. Mankani MH, Kuznetsov SA, Marshall GW, et al. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 2008; 14: 1949-1958.
52. Carragee EJ, Hurwitz EL, Weiner BK,. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 2011; 11: 471-491.